<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Br J Cancer</journal-id><journal-title>British Journal of Cancer</journal-title><issn pub-type="ppub">0007-0920</issn><issn pub-type="epub">1532-1827</issn></journal-meta><article-meta><article-id pub-id-type="pmid">6688531</article-id><article-id pub-id-type="pmc">2011475</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Multivariate analyses as aids to diagnosis and assessment of prognosis in gastrointestinal cancer.</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>de Mello</surname><given-names>J.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Struthers</surname><given-names>L.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Turner</surname><given-names>R.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Cooper</surname><given-names>E. H.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Giles</surname><given-names>G. R.</given-names></name></contrib></contrib-group><pub-date pub-type="ppub"><month>9</month><year>1983</year></pub-date><volume>48</volume><issue>3</issue><fpage>341</fpage><lpage>348</lpage><abstract><p>The role of carcinoembryonic antigen (CEA), gamma glutamyl transpeptidase (gamma GT), phosphohexose isomerase (PHI), pseudouridine (psi) and acute phase reactant proteins (C-reactive protein (CRP) alpha 1-antichymotrypsin (ACT) and alpha 1-acid glycoprotein (AGP] in assessing the prognosis of gastrointestinal neoplasms and the discriminant function in distinguishing benign from malignant diseases of the GI tract was examined. In stomach cancer pre-operative levels of CRP can help in the identification of the patients with a resectable tumour; the pre-operative biochemical measurements do not give any further information on prognosis once stage and site are taken into account. In colorectal cancer pre-operative ACT levels give additional prognostic information once the clinical factors, Dukes stage, sex and age have been accounted for; PHI levels are on the border line of significance. A discriminant function has been devised using sex, CEA, psi, gamma GT, ACT and PHI that can identify 89% of Dukes "D" patients prior to surgery with a misclassification of 7% of other cases of colorectal cancer. A discriminant function using all the biochemical variates separated the cancer from non-cancer patients. The false positive rate for cancer was 16% and a false negative rate of 19%, when the cut-off level was set at 0.7.</p></abstract></article-meta></front><body><supplementary-material content-type="scanned-pages"><graphic xlink:href="brjcancer00420-0014.tif" xlink:title="scanned-page" xlink:role="341" mimetype="image" mime-subtype="tiff"/><graphic xlink:href="brjcancer00420-0015.tif" xlink:title="scanned-page" xlink:role="342" mimetype="image" mime-subtype="tiff"/><graphic xlink:href="brjcancer00420-0016.tif" xlink:title="scanned-page" xlink:role="343" mimetype="image" mime-subtype="tiff"/><graphic xlink:href="brjcancer00420-0017.tif" xlink:title="scanned-page" xlink:role="344" mimetype="image" mime-subtype="tiff"/><graphic xlink:href="brjcancer00420-0018.tif" xlink:title="scanned-page" xlink:role="345" mimetype="image" mime-subtype="tiff"/><graphic xlink:href="brjcancer00420-0019.tif" xlink:title="scanned-page" xlink:role="346" mimetype="image" mime-subtype="tiff"/><graphic xlink:href="brjcancer00420-0020.tif" xlink:title="scanned-page" xlink:role="347" mimetype="image" mime-subtype="tiff"/><graphic xlink:href="brjcancer00420-0021.tif" xlink:title="scanned-page" xlink:role="348" mimetype="image" mime-subtype="tiff"/></supplementary-material></body></article>

